They are staff members of the Institute of Experimental Genetics. Metronomic chemotherapy and repositioning of drugs are the main investigations in progress.
LIF’s Board of Directors and Trustee welcomed researchers and maintenance a meeting where they could exchange information about the different activities of both institutions.
“IGE works in basic research to produce pre clinical knowledge. The objective is reduce the time between the development of a new therapy and the use in patients. It is an interactive work between researchers and physicians,” expressed MD Graciela Scharovsky, IGE’s Director.
“IGE works in basic research to produce pre clinical knowledge. The objective is reduce the time between the development of a new therapy and the use in patients. It is an interactive work between researchers and physicians,” expressed MD Graciela Scharovsky, IGE’s Director.
For more than 15 years, IGE has been working in Chemotherapy and repositioning of drugs.
Metronomic chemotherapy is defined as repeated administration of anti-neoplastic drugs at comparatively low doses frequently and without long drug-free period.
Metronomic chemotherapy is defined as repeated administration of anti-neoplastic drugs at comparatively low doses frequently and without long drug-free period.
After meeting, the visitors explored the different LIF’s facilities.
IGE: Institute of Experimental Genetics.
UNR: Universidad Nacional de Rosario - National University of Rosario.
CONICET: Consejo Nacional de Investigaciones CientÃficas y Técnicas - National Committee of Scientific and Technical Research.
